Disease severity and efficacy of homologous vaccination among patients infected with SARS-CoV-2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkers.

Ali AM, Tofiq AM, Rostam HM, Ali KM, Tawfeeq HM

Open source

DOI
10.1002/jmv.28098
Published
2022 Dec
Container
Journal of medical virology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/jmv.28098,
  title = {Disease severity and efficacy of homologous vaccination among patients infected with SARS-CoV-2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkers.},
  author = {Ali AM and Tofiq AM and Rostam HM and Ali KM and Tawfeeq HM},
  year = {2022},
  journal = {Journal of medical virology},
  doi = {10.1002/jmv.28098},
  url = {https://doi.org/10.1002/jmv.28098}
}

RIS

TY  - JOUR
TI  - Disease severity and efficacy of homologous vaccination among patients infected with SARS-CoV-2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkers.
AU  - Ali AM
AU  - Tofiq AM
AU  - Rostam HM
AU  - Ali KM
AU  - Tawfeeq HM
PY  - 2022
JO  - Journal of medical virology
DO  - 10.1002/jmv.28098
UR  - https://doi.org/10.1002/jmv.28098
ER  - 

APA

AM, A., AM, T., HM, R., KM, A., & HM, T. (2022). Disease severity and efficacy of homologous vaccination among patients infected with SARS-CoV-2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkers.. Journal of medical virology. https://doi.org/10.1002/jmv.28098

Source records